Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
15.56
+0.39 (2.57%)
At close: Aug 22, 2025, 4:00 PM
15.55
-0.01 (-0.06%)
After-hours: Aug 22, 2025, 6:57 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $631.98 million as of August 22, 2025. Its market cap has decreased by -62.90% in one year.
Market Cap
631.98M
Enterprise Value
-40.29M
1-Year Change
-62.90%
Ranking
Category
Stock Price
$15.56
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $631.98M, an increase of 64.01%. That is a compound annual growth rate of 9.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 631.98M | -1.44% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |